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doi:10.1016/j.ejvs.2011.05.021Abstract Aim: The decision for abdominal aortic aneurysm (AAA) repair is based on aneu-
rysm size. However, smaller aneurysms can rupture, while larger ones can remain stable.
New variables and markers are needed to better select patients at high rupture risk. The study
was done to analyse if AAA patients have increased levels of circulating basement-membrane
(BM) fragments.
Design: Circulating levels of BM components type IV and XVIII collagen were measured by
enzyme-linked immunosorbent assay (ELISA) in 10 patients with AAA, nine patients with
peripheral artery disease (PAD) and 10 healthy controls (CON).
Results: AAA patients had significantly increased levels of type IV and XVIII collagen compared
with CON (134.0  24.8 ng ml1 vs. 104.5  16.4 ng ml1; pZ 0.005 and 149.0  56.9 ng ml1
vs. 59.6  8.7 ng ml1; p < 0.001, respectively). The PAD patients did not have significantly
increased levels of these fragments when compared with CON. In addition, the AAA patients
had significantly increased level of type XVIII collagen (149.0  56.9 ng ml1 vs.
58.3  25.4 ng/ml1; p < 0.01) when compared with the PAD group.
Conclusion: Based on this preliminary analysis of a small number of subjects, patients with AAA
had significantly increased levels of circulating BM components. BM fragments should be
studied further to establish their potential role as biomarkers for AAA.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Abdominal aortic aneurysm (AAA) formation is a complex
process characterised by degeneration and remodelling of
the extracellular matrix (ECM) in the vessel wall. These ECM0 785 0000; fax: þ46 90 785
ry.umu.se (M. Sund).
ty for Vascular Surgery. Publishechanges subsequently lead to dilatation, weakness and
eventual rupture of the aortic wall.1 Matrix metal-
loproteinases (MMPs) are a family of proteases involved in
the degeneration and remodelling of ECM in most tissues. In
the aorta, MMP2 and MMP9 seem to have an important role
in degrading elastin and collagen.2,3 High MMP2 activity has
been found to be important for aneurysm expansion,
whereas MMP9 activity appears to be associated with bothd by Elsevier Ltd. All rights reserved.
Circulating Basement-Membrane Fragments in AAA 485aneurysm rupture and expansion.2,4 However, recent
studies have indicated that the value of analysing these
MMPs as biomarkers for AAA growth is limited.5 It has also
been shown that the circulating levels of MMPs are not
correlated to the tissue concentration in the vessel wall,6
which indicates the importance of the proteolytic frag-
ments as a reflection of the proteolytic activity in the
tissue.
In addition to MMPs, many proteins and protein frag-
ments have been evaluated as AAA markers, including
tissue inhibitors of matrix metalloproteinases (TIMPs);
adventitial collagens, such as type I and III collagens;
plasminogen activator inhibitor type 1 (PAI-1/serpine-1);
activated protein C-protein C inhibitor complex (APC-PCI);
and D-dimer.5,7e9
BMs are sheets of highly specialised ECM, which are
found at the epithelial/mesenchymal interface of most
tissues. In blood vessels, the BM separates the endothelium
lining of the vessel from the pericyte layer.10 The BM not
only serves as a structural barrier but also influences
multiple biological activities, such as cell adhesion, prolif-
eration, differentiation and migration.10 Type IV collagen is
the main component of all BM, but this ECM also contains
many other proteins, such as laminins, types XV and XVIII
collagens, perlecan and nidogen.10
It has been shown in patients with thoracic aortic aneu-
rysms that the BM undergoes major structural alterations.11
However, the circulating level of BM fragments in patients
with AAA has not been studied previously. The aim of this
pilot study was to analyse whether patients with AAA have
increased circulating levels of two BM components, namely
type IV and XVIII collagen, when compared to healthy
controls and patients with peripheral artery disease (PAD).
Materials and Methods
Patients and samples
Ten AAA patients (AAA > 50 mm) referred to the Vascular
Surgery Unit of the Department of Surgery at Umea˚
University Hospital for surgical treatment of the aneurysms
offered to participate in the study. Two control groups were
recruited. One group consisted of healthy controls (CON;
n Z 10) undergoing elective cholecystectomy and without
a history of AAA or atherosclerosis. The second groupTable 1 Patient characteristics.
AAA
n Z 10
PAD
n Z 9
CON
n Z
Sex ratio (M:F) 9:1 8:1 4:6
Mean age (range) 68 (65e80) 77 (60e90) 52 (
Smoking (Yes/No) 9/1 3/6 0/10
Hypertension (Yes/No) 8/2 6/3 0/10
Diabetes (Yes/No) 1/9 2/7 0/10
Hyperlipidemia (Yes/No) 9/1 2/7 0/10
Size of aneurysm (mm) 60.69.7 e e
Abbreviations: AAA Z Abdominal aortic aneurysm, PAD Z Peripheral
* These parameters almost reached significance, p Z 0.06.consisted of patients with PAD (PAD; n Z 10). Diagnoses of
individuals in both control groups were verified by ultra-
sound to not have an AAA. One PAD patient was subse-
quently found to have an aneurysm and was therefore
excluded from the group. Detailed patient characteristics
are shown in Table 1. The diagnosis of hypertension,
hyperlipidaemia and/or diabetes in the patient’s chart,
combined with ongoing medication, was used as a marker
for disease. The Research Ethics Review Board (EPN) of
Northern Sweden approved the study, and all patients gave
written informed consent for use of the samples for
research. Blood samples were collected before surgery into
ethylene diamine tetraacetic acid (EDTA) tubes, and
plasma was isolated. Samples were stored at 80 C until
analysis.
ELISA
Plasma samples were analysed for circulating type IV and
XVIII collagen fragments in duplicates, using the Collagen IV
enzyme immunoassay (EIA) (Argutus Medical, Dublin,
Ireland) and Quantikine Human Endostatin Immunoassay
(R&D Systems, Minneapolis, MN, USA). Both assays were
performed according to the manufacturer’s protocol.
Duplicate samples with intra-assay variance (CV%) of more
than 10% were rerun. The sensitivity (minimum detectable
dose) for the assays is 15.6 ng ml1 and 0.023 ng ml1, for
type IV and type XVIII collagen, respectively.
Statistical analysis
All variables showed normal distribution. Statistical analysis
was performed with one-way analysis of variance (ANOVA)
with Bonferroni post hoc test for the comparison of circu-
lating levels of type IV and XVIII collagens as well as age
distribution between the three groups. Fisher’s exact test
was used when comparing other characteristics of the three
groups. A p-value <0.05 was considered as statistically
significant. InStat3 software (GraphPad Inc. La Jolla, CA,
USA) was used.
Results
Patients with AAA had significantly increased circulating
levels of the BM protein type XVIII collagen, when compared10
p-value
(AAA vs PAD)
p-value
(AAA vs CON)
p-value
(PAD vs CON)
n.s. n.s.* n.s.*
36e78) n.s. 0.05 0.001
0.02 0.0001 n.s.
n.s. 0.0007 0.003
n.s. n.s. n.s.
n.s. 0.0001 0.003
artery disease, CON Z Control, n.s. Z Not significant
486 M. Ramazani et al.with patients with PAD (149.0  56.9 ng ml1 vs.
58.3  25.4 ng ml1; p < 0.001) and when compared with
healthy controls (149.0  56.9 ng ml1 vs.
59.6  8.7 ng ml1; p < 0.001). No significant difference
was observed in the circulating levels of type XVIII collagen
when comparing the healthy controls with the patients with
PAD (Fig. 1(A).
The circulating levels of another BM component, type IV
collagen, were also significantly increased in patients with
AAA when compared with healthy controls
(134.1  24.8 ng ml1 vs. 104.5  16.4 ng/ml1; p < 0.01)
(Fig. 1(B)). However, no significant difference in the
circulating levels was observed either when comparing the
AAA patients with those with PAD or when comparing the
patients with PAD with the healthy controls (Fig. 1(B)).
Discussion
In a previous study on thoracic aortic aneurysms, major
structural changes were observed in the BM of the aneu-
rysmal aortic wall when compared with the normal aortic
vessel wall. An up-regulation of the expression of several
BM components was observed, and the BM became
increasingly thick.11 It is also known from previous studies
that there is a significant up-regulation of MMP activity in
the aortic wall of an aneurysm.2 MMP2 and MMP9 activity is
increased, and both of these proteases are known to
degrade many BM proteins, including both type IV and XVIII
collagen,12,13 which are then released into the circulation.0
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Figure 1 Circulating levels of type XVIII collagen (A) and type
IV collagen (B) fragments in patients AAA, PAD and healthy
controls (CON). Abbreviations: NS Z non significant,
AAA Z abdominal aortic aneurysm, CON Z control and
PAD Z peripheral artery disease. Number of patients is 10 in
AAA and CON groups and 9 in PAD group.The aim of our study was to analyse whether patients with
AAA have increased circulating levels of BM components,
when compared with PAD patients and healthy controls.
Our results show fragments from both BM collagens are
significantly increased in patients with AAA when compared
with healthy controls. In addition, when compared with
patients with PAD, significantly increased levels of type
XVIII collagen were observed, but, for type IV collagen, the
increase was not statistically significant. No statistically
significant difference was observed in the patients with PAD
when compared with controls. Previous studies have shown
that there are no differences between the sexes in the
levels of these fragments.14,15 The levels also remain stable
with increasing age; however, the levels tend to increase
somewhat in individuals older than 75 years.14,16
Several ECM components from the adventitial ECM, such
as type I and III collagen, have been studied in AAA
patients, but fragments from these have not been estab-
lished as biomarkers in monitoring AAA disease develop-
ment.7,8 The findings in this pilot study of increased
circulating levels of BM components in patients with AAA
should be verified in larger patient cohorts. In addition, the
effect of AAA size and expansion on these levels should be
carefully characterised. For type XVIII collagen, a differ-
ence in circulating levels was found between AAA and PAD
patients. Interestingly, this was not observed for type IV
collagen fragments. This difference in the levels of type IV
and XVIII collagen, found when comparing patients with
AAA and PAD, indicates that BM fragments can be cleaved
from the vessel wall at different stages of vascular
remodelling and potentially serve as markers of these
processes. Finally, the effect of both surgical and endo-
vascular intervention on these levels will be addressed in
future studies.
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